Research Article
Comprehensive Analysis of NPSR1-AS1 as a Novel Diagnostic and Prognostic Biomarker Involved in Immune Infiltrates in Lung Adenocarcinoma
Table 2
Univariate and multivariate analysis of different prognostic factors for overall survival in patients with LUAD.
| Characteristics | Total () | Univariate analysis | Multivariate analysis | Hazard ratio (95% CI) | value | Hazard ratio (95% CI) | value |
| Gender | 526 | | | | | Female | 280 | Reference | | | | Male | 246 | 1.070 (0.803-1.426) | 0.642 | | | Age | 516 | | | | | ≤65 | 255 | Reference | | | | >65 | 261 | 1.223 (0.916-1.635) | 0.172 | | | Pathologic stage | 518 | | | | | Stage I & stage II | 411 | Reference | | | | Stage III & stage IV | 107 | 2.664 (1.960-3.621) | <0.001 | 2.535 (1.860-3.455) | <0.001 | NPSR1-AS1 | 526 | | | | | Low | 263 | Reference | | | | High | 263 | 1.557 (1.165-2.081) | 0.003 | 1.442 (1.074-1.936) | 0.015 |
|
|